Center on Health Equity & Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Press Releases

Product Approvals and Launches

Video

All Video Types

AJMC TV

Insights

OnLocation

Payer Perspectives

Peer Exchange

Post Conference Perspectives

Stakeholder Summit

Podcasts

Conferences

Conference Coverage

Conference Listing

Journals

All Journals

The American Journal of Managed Care

Population Health, Equity & Outcomes

Evidence-Based Oncology

About Supplements and Featured Publications

Supplements and Featured Publications Issues

Submit a Manuscript

Events

Institute for Value-Based Medicine

Patient-Centered Oncology Care

Resources

Interactive Tools

Clinical Spotlight

Microsites

About AJMC

AJMC Staff

Anniversary

Seema Sonnad Award

Strategic Alliance Partners

Subscribe

Articles

The new drug application (NDA) includes data from a global placebo-controlled, 72-week study as well as findings from the STRIDE registry, an ongoing, observational, real-world study of ataluren in routine care.

FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy

Iron deficiency represents more than a medical condition; it is a reflection of persistent health disparities, according to an editorial published in The Lancet Haematology.

A Case for Iron Deficiency as a Marker of Inequality in Care Access and Treatment

Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Cameron Santoro is an associate editor for 

), AJMC.com, and The Center for Biosimilars

Global Biosimilars Week discussed issues in biosimilar adoption and called for reforms to streamline processes, foster competition, and increase biosimilar access for patients.

Addressing Patent Hurdles, Payer Barriers, and Interchangeability

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About

Contact

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

Instagram

Specialty Area

Biosimilars

Cardiorenalmetabolic

Dermatology

Hematology

Hepatology

Immunology

Infectious Disease

Mental Health

Neurology

Obesity

Oncology

Ophthalmology

Pulmonology

Rare Disease

Respiratory

Rheumatology

Women's Health

Spotlight

Free In-Person Regional Events Focused on Oncology and Population Health

Topics

Digital Health

Formulary

Gene Therapy

Guidelines

Health Care Administration

Population Health

All Coverage

Event Coverage

Interviews

AJMC Journals

Author Forms

Authors

Nominate a Rising Leader

View

Participating Faculty: Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update

Introduction to Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update

Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current Evidence

Biosimilar medicines: what are they and how are they used?

Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys

What do patients and health care providers still need to know about biosimilar medicines?

eAppendix: Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys

Biosimilars for Immune-Mediated Inflammatory Diseases – A Managed Care Perspective

What are the current challenges to wider biosimilar use in the United States?

Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update

Supplements and Featured Publications

What are the current challenges to wider biosimilar use in the United States?

Plain Language Summary